Related Experiment Video
Updated: Jan 8, 2026

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
Published on: April 21, 2022
Retinal Vascular Occlusion in Patients on Anticoagulation and Antiplatelet Therapy: a Case Report and Comprehensive
Malek Madi1, Adham Harb1, Nour Jabbour1
1Department of Ophthalmology and Visual Sciences, University of Balamand, Advanced Eye Care Hospital, Lebanon.
Abstract:
The purpose of this study was to evaluate any protective role of anti-platelet and/or anticoagulation therapy in preventing retinal vascular occlusions, whether arterial or venous. We have described the case of a 47-year-old male who presented with a left-eye branched retinal artery occlusion despite being on both anticoagulation and anti-platelet therapy. A narrative literature review of reports published between 2000 and 2024 identified twelve relevant articles, which collectively indicated no protective or preventive benefit of anti-platelet or anticoagulant therapy against retinal vascular occlusions.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction

